|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Comprehensive application of modern technologies in precise liver resection显示文摘BACKGROUND: Liver surgery has gone through the phases of wedge liver resection, regular resection of hepatic lobes, irregular and local resection, extracorporeal hepatectomy, hemi-extracorporeal hepatectomy and Da Vinci surgical system-assisted hepatectomy. Taking advantage of modern technologies, liver surgery is stepping into an age of precise liver resection. This review aimed to analyze the comprehensive application of modern technologies in precise liver resection. DATA SOURCE: PubMed search was carried out for English-language articles relevant to precise liver resection, liver anatomy, hepatic blood inflow blockage, parenchyma transection, and down-staging treatment. RESULTS: The 3D image system can imitate the liver operation procedures, conduct risk assessment, help to identify the operation feasibility and confirm the operation scheme. In addition, some techniques including puncture and injection of methylene blue into the target Glisson sheath help to precisely determine the resection. Alternative methods such as Pringle maneuver are helpful for hepatic blood inflow blockage in precise liver resection. Moreover, the use of exquisite equipment for liver parenchyma transection, such as cavitron ultrasonic surgical aspirator, ultrasonic scalpel, Ligasure and Tissue Link is also helpful to reduce hemorrhage in liver resection, or even operate exsanguinous liver resection without blocking hepatic blood flow. Furthermore, various down-staging therapies including transcatheter arterial chemoembolization and radio-frequency ablation were appropriate for unresectable cancer, which reverse the advanced tumor back to early phase by local or systemic treatment so that hepatectomy or liver transplantation is possible.CONCLUSIONS: Modern technologies mentioned in this paper are the key tool for achieving precise liver resection and can effectively lead to maximum preservation of anatomical structural integrity and functions of the remnant liver. In addition, large randomized trials are needed to evaluate the usefulness of these technologies in patients with hepatocellular carcinoma who have undergone precise liver resection. | Nian-Song Qian Yong-Hui Liao Shou-Wang Cai Vikram Raut Jia-Hong Dong | 2013 | Hepatobiliary & Pancreatic Diseases International2013，12，3： | 27 |
| 2 | Management of nocturnal enuresis-myths and facts显示文摘Nocturnal enuresis often causes considerable distress or functional impairment to patient and their parents necessitating a multidisciplinary approach from paediatrician, paediatric nephrologist, urologists and psychiatrist. Mechanisms of monosymptomatic nocturnal enuresis are mainly nocturnal polyuria, bladder overactivity and failure to awaken from sleep in response to bladder sensations. Goal oriented and etiology wise treatment includes simple behavioral intervention, conditioning alarm regimen and pharmacotherapy with desmopressin, imipramine and anticholinergic drugs. Symptoms often recurs requiring change over or combination of different modes of treatment. | Rajiv Sinha Sumantra Raut | 2016 | World Journal of Nephrology2016，5，4： | 18 |
| 3 | Serum uric acid level in newly diagnosed essential hypertension in a Nepalese population:A hospital based cross sectional study显示文摘Objective:To develop the missing link between hyperuricemia and hypertension.Methods:The study was conducted in Department of Biochemistry in collaboration with Nephrology Unit of Internal Medicine Department.Hypertension was defined according to blood pressure readings by definitions of the Seventh Report of the Joint National Committee.Totally 205newly diagnosed and untreated essential hypertensive cases and age-sex matched nonnotensive controls were enrolled in the study.The potential confounding factors of hyperuricemia and hypertension in both cases and controls were controlled.Uric acid levels in all participants were analyzed.Results:Renal function between newly diagnosed hypertensive cases and nonnotensive healthy controls were adjusted.The mean serum uric acid observed in newly diagnosed hypertensive cases and in nonnotensive healthy controls were(290.05±87.03)μmol/L and(245.24±09.38)μmol/L respectively.A total of 59(28.8%)participants of cases and 28(13.7%)participants of controls had hyperuricemia(odds ratio 2.555(95%CI:1.549-4.213),P<0.00l).Conclusions:The mean serum uric acid leveb and number of hyperuricemic subjects were found to be significantly higher in cases when compared to controls. | Bibek Poudel Binod Kumar Yadav Arun Kumar Bharat Jha Kanak Bahadur Raut | 2014 | Asian Pacific Journal of Tropical Biomedicine2014，4，1： | 10 |
| 4 | Pancreaticoduodenectomy with vascular resection: margin status and survival duration显示文摘 | Jennifer F. Tseng M.D. Chandrajit P. Raut M.D. Jeffrey E. Lee M.D. Peter W. T. Pisters M.D. Jean-Nicolas Vauthey M.D. Eddie K. Abdalla M.D. Henry F. Gomez M.D. Charlotte C. Sun Dr.P.H. Christopher H. Crane M.D. Robert A. Wolff M.D. Douglas B. Evans M.D | 2004 | Journal of Gastrointestinal Surgery2004，，8： | 6 |
| 5 | Pediatric lupus nephritis: Management update显示文摘Childhood-onset systemic lupus erythematosus(c SLE) is a severe multisystem autoimmune disease. Renal involvement occurs in the majority of c SLE patients and is often fatal. Renal biopsy is an important investigation in the management of lupus nephritis. Treatment of renal lupus consists of an induction phase and maintenance phase. Treatment of childhood lupus nephritis using steroids is associated with poor outcome and excess side-effects. The addition of cyclophosphamide to the treatment schedule has improved disease control. In view of treatment failure using these drugs and a tendency for non-adherence, many newer agents such as immune-modulators and monoclonal antibodies are being tried in patients with c SLE. Trials of these novel agents in the pediatric population are still lacking making a consensus in the management protocol of pediatric lupus nephritis difficult. | Rajiv Sinha Sumantra Raut | 2014 | World Journal of Nephrology2014，3，2： | 4 |
| 6 | 用椰壳制活性炭吸附去除三价铋离子(英文)显示文摘In present study,we report the preparation of coconut shell activated carbon as adsorbent and its appli-cation for Bi(Ⅲ) removal from aqueous solutions.The developed adsorbent was characterized with scanning elec-tron microscope(SEM),Fourier Transform Infrared(FTIR),C,H,N,S analyzer,and BET surface area analyzer.The parameters examined include agitation time,initial concentration of Bi(Ⅲ),adsorbent dose and temperature.The maximum adsorption of Bi(Ⅲ)(98.72%) was observed at 250 mg·L-1 of Bi(Ⅲ) and adsorbent dose of 0.7 g when agitation was at 160 r·min-1 for 240 min at(299±2) K.The thermodynamic parameters such as Gibb's free energy(△Gθ),enthalpy(△Hθ) and entropy(△Sθ) were evaluated.For the isotherm models applied to adsorption study,the Langmuir isotherm model fits better than the Freundlich isotherm.The maximum adsorption capacity from the Langmuir isotherm was 54.35 mg?g?1 of Bi(Ⅲ).The kinetic study of the adsorption shows that the pseudo second order model is more appropriate than the pseudo first order model.The result shows that,coconut shell ac-tivated carbon is an effective adsorbent to remove Bi(Ⅲ) from aqueous solutions with good adsorption capacity. | SARTAPE Ashish MANDHARE Aniruddha SALVI Prathmesh PAWAR Dattatraya RAUT Prakash ANUSE Mansing KOLEKAR Sanjay | 2012 | Chinese Journal of Chemical Engineering2012，20，4： | 3 |
| 7 | Intraductal Papillary Mucinous Neoplasms of the Pancreas: Effect of Invasion and Pancreatic Margin Status on Recurrence and Survival显示文摘 | Chandrajit P. Raut MD Karen R. Cleary MD Gregg A. Staerkel MD James L. Abbruzzese MD Robert A. Wolff MD Jeffrey H. Lee MD Jean-Nicolas Vauthey MD Jeffrey E. Lee MD Peter W. T. Pisters MD Douglas B. Evans MD | 2006 | Annals of Surgical Oncology2006，，4： | 3 |
| 8 | Small intestine gastrointestinal stromal tumors显示文摘 | Shilpa Grover Stanley W. Ashley Chandrajit P. Raut | 2012 | Current Opinion in Gastroenterology2012，，2： | 2 |
| 9 | Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab显示文摘 | Raut V Mori A Kaido T | 2012 | Transplantation2012，，01： | 2 |
| 10 | Pancreaticoduodenectomy with vascular resection: margin status and survival duration显示文摘 | Jennifer F. Tseng Chandrajit P. Raut Jeffrey E. Lee Peter W.T. Pisters Jean-Nicolas Vauthey Eddie K. Abdalla Henry F. Gomez Charlotte C. Sun Christopher H. Crane Robert A. Wolff Douglas B. Evans | 2004 | Journal of Gastrointestinal Surgery2004，，8： | 2 |
| 11 | Mapping of QTL for agronomic traits and kernel characters in durum wheat ( Triticum durum Desf.)显示文摘 | R. M. Patil S. A. Tamhankar M. D. Oak A. L. Raut B. K. Honrao V. S. Rao S. C. Misra | 2013 | Euphytica2013，，1： | 2 |
| 12 | Splenectomy Does Not Offer Immunological Benefits in ABO-Incompatible Liver Transplantation With a Preoperative Rituximab显示文摘 | Vikram Raut Akira Mori Toshimi Kaido Yasuhiro Ogura Iida Taku Kazuyuki Nagai Naoya Sasaki Kosuke Endo Toshiyuki Hata Shintaro Yagi Hiroto Egawa Shinji Uemoto | 2012 | Transplantation2012，，1： | 2 |
| 13 | Laparoscopic left lateral resection is the gold standard for benign liver lesions: a case–control study显示文摘 | Safi Dokmak Vikram Raut Béatrice Aussilhou Fadhel Samir Ftériche Olivier Farges Alain Sauvanet Jacques Belghiti | 2014 | HPB2014，，2： | 2 |
| 14 | Intravesical bacillus Calmette-Guerin(BCG)in treating non-muscle invasive bladder cancer—analysis of adverse effects and effectiveness of two strains of BCG(Danish 1331 and Moscow-I)显示文摘Objective:To compare the differences in adverse effects and efficacy profile between bacillus Calmette-Guerin(BCG)Danish 1331 and BCG Moscow-I strain in management of non-muscle invasive bladder cancer.Methods:Clinical data of 188 cases of non-muscle invasive bladder cancer treated with BCG between January 2008 and December 2018 in our institute were collected prospectively and analysed retrospectively,and 114 patients who completed a minimum of 12 months of follow-up were analysed.Patient and tumor characteristics,strain of BCG,adverse effects,and tumor progression were included for analysis.Intravesical BCG was instilled in intermediate-and high-risk patients.Six weeks of induction BCG,followed by three weekly maintenance BCG at 3,6,12,18,and 24 months was advised in high-risk patients.Results:Overall 68 patients received BCG Danish 1331 strain and 46 patients received Moscow-I strain.Patient and tumor characteristics were well balanced between the two groups.The median follow-up period was 42.5 months and 34.5 months in Danish 1331 and Moscow-I groups,respectively.Adverse events like dropout rate,antitubercular treatment requirement,and need of cystectomy were higher in Moscow-I group(n=31,67.4%)when compared to Danish 1331 strain(n=33,48.5%)(p=0.046).On direct comparison between Danish 1331 and Moscow-I strain,there was similar 3-year recurrence-free survival(80.0%vs.72.9%)and 3-year progression-free survival(96.5%vs.97.8%).Conclusion:Study results suggest no significant differences between Danish 1331 and Moscow-I strain in recurrence-free survival and progression-free survival,but a significantly higher incidence of moderate to severe adverse events in BCG Moscow-I strain. | Yuvaraja B.Thyavihally Preetham Dev Santosh Waigankar Abhinav Pednekar Nevitha Athikari Abhijit Raut Archan Khandekar Naresh Badlani Ashishkumar Asari | 2022 | Asian Journal of Urology2022，9，2： | 2 |
| 15 | Management of ABO-incompatible living-donor liver transplantation:past and present trends显示文摘 | Raut V Uemoto S | 2011 | Surgery Today(Japanese Journal of Surgery )2011，，03： | 1 |
| 16 | Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis显示文摘 | Raut CP Izzo F Marra P | 2005 | Ann Surg Oncol2005，12，8： | 1 |
| 17 | Current issues in gastrointestinal stromal tumors:incidence,molecular biology,and contemporary treatment of localized and advanced disease显示文摘 | Raut CP Morgan JA Ashley SW | 2007 | Curr Opin Gastroenterol2007，23，2： | 1 |
| 18 | Management of bile duct injuries and strictures following cholecystectomy显示文摘 | Raute M Podlceh P Jaschke W | 1993 | World Surg1993，17，4： | 1 |
| 19 | A study of quality factors of yak fiber显示文摘 | Ghoshal S P Raut S D Jaiswal P K | 1993 | Wool & Woollens of India1993，30，4： | 1 |
| 20 | Activator protein 2alpha status determines the chemosensitivity of cancer cells:implications in cancer chemotherapy 显示文摘 | Wajapeyee N Raut CG Somasundaram K | 2005 | Cancer Res2005，65，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员